Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 May;79(5):439–441. doi: 10.1136/bjo.79.5.439

Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium.

J Cano-Parra 1, M Diaz-Llopis 1, M J Maldonado 1, E Vila 1, J L Menezo 1
PMCID: PMC505131  PMID: 7612555

Abstract

AIMS--A prospective, randomised, double blind, placebo controlled study of intraoperative mitomycin C as adjunctive treatment of primary pterygium was conducted. METHODS--A total of 66 eyes of 54 patients with primary pterygium were treated with excision, with or without a single intraoperative application of mitomycin C (0.1 mg/ml for 5 minutes) to evaluate the efficacy and toxicity of this adjunctive treatment. The mean follow up was 14.1 months (range 12-23 months). RESULTS--Of the 36 eyes that underwent simple excision, 14 (38.8%) exhibited recurrences whereas only one of 30 eyes (3.33%) treated with excision and intraoperative application of mitomycin C had recurrence (p = 0.0006). Neither serious ocular complications nor systemic toxicity were noted in the mitomycin C treated group. CONCLUSION--Intraoperative mitomycin C appears to be an effective and safe adjunctive treatment of primary pterygium.

Full text

PDF
439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cameron M. E. Histology of pterygium: an electron microscopic study. Br J Ophthalmol. 1983 Sep;67(9):604–608. doi: 10.1136/bjo.67.9.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. D'Ombrain A. THE SURGICAL TREATMENT OF PTERYGIUM. Br J Ophthalmol. 1948 Feb;32(2):65–71. doi: 10.1136/bjo.32.2.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Flament J., Speeg-Schatz C., Weber M. Etat actuel du traitement du ptérygion. J Fr Ophtalmol. 1993;16(6-7):401–410. [PubMed] [Google Scholar]
  4. Frucht-Pery J., Ilsar M. The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology. 1994 Apr;101(4):759–762. doi: 10.1016/s0161-6420(94)31269-3. [DOI] [PubMed] [Google Scholar]
  5. Hayasaka S., Noda S., Yamamoto Y., Setogawa T. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol. 1988 Dec 15;106(6):715–718. doi: 10.1016/0002-9394(88)90706-4. [DOI] [PubMed] [Google Scholar]
  6. Kenyon K. R., Wagoner M. D., Hettinger M. E. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985 Nov;92(11):1461–1470. doi: 10.1016/s0161-6420(85)33831-9. [DOI] [PubMed] [Google Scholar]
  7. Khaw P. T., Sherwood M. B., MacKay S. L., Rossi M. J., Schultz G. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol. 1992 Aug;110(8):1150–1154. doi: 10.1001/archopht.1992.01080200130040. [DOI] [PubMed] [Google Scholar]
  8. Lewallen S. A randomized trial of conjunctival autografting for pterygium in the tropics. Ophthalmology. 1989 Nov;96(11):1612–1614. doi: 10.1016/s0161-6420(89)32667-4. [DOI] [PubMed] [Google Scholar]
  9. MEACHAM C. T. Triethylene thiophosphoramide in the prevention of pterygium recurrence. Am J Ophthalmol. 1962 Nov;54:751–753. [PubMed] [Google Scholar]
  10. Mackenzie F. D., Hirst L. W., Battistutta D., Green A. Risk analysis in the development of pterygia. Ophthalmology. 1992 Jul;99(7):1056–1061. doi: 10.1016/s0161-6420(92)31850-0. [DOI] [PubMed] [Google Scholar]
  11. Mahar P. S., Nwokora G. E. Role of mitomycin C in pterygium surgery. Br J Ophthalmol. 1993 Jul;77(7):433–435. doi: 10.1136/bjo.77.7.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. ROCK R. L. Inhibition of corneal vascularization by triethylene thiophosphoramide (Thio-Tepa). Arch Ophthalmol. 1963 Mar;69:330–334. doi: 10.1001/archopht.1963.00960040336015. [DOI] [PubMed] [Google Scholar]
  13. Rubinfeld R. S., Pfister R. R., Stein R. M., Foster C. S., Martin N. F., Stoleru S., Talley A. R., Speaker M. G. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992 Nov;99(11):1647–1654. doi: 10.1016/s0161-6420(92)31749-x. [DOI] [PubMed] [Google Scholar]
  14. Singh G., Wilson M. R., Foster C. S. Mitomycin eye drops as treatment for pterygium. Ophthalmology. 1988 Jun;95(6):813–821. doi: 10.1016/s0161-6420(88)33104-0. [DOI] [PubMed] [Google Scholar]
  15. Tarr K. H., Constable I. J. Late complications of pterygium treatment. Br J Ophthalmol. 1980 Jul;64(7):496–505. doi: 10.1136/bjo.64.7.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yamamoto T., Varani J., Soong H. K., Lichter P. R. Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology. 1990 Sep;97(9):1204–1210. doi: 10.1016/s0161-6420(90)32456-9. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES